125 related articles for article (PubMed ID: 1998948)
1. Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.
Singh M; Ghose T; Mezei M; Belitsky P
Cancer Lett; 1991 Feb; 56(2):97-102. PubMed ID: 1998948
[TBL] [Abstract][Full Text] [Related]
2. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M
Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model.
Singh M; Ghose T; Kralovec J; Blair AH; Belitsky P
Cancer Immunol Immunother; 1991; 32(5):331-4. PubMed ID: 1998974
[TBL] [Abstract][Full Text] [Related]
4. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human renal cancer by methotrexate linked to a monoclonal antibody.
Singh M; Kralovec J; Mezei M; Ghose T
J Urol; 1989 Feb; 141(2):428-31. PubMed ID: 2643730
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
Luner SJ; Ghose T; Chatterjee S; Cruz HN; Belitsky P
Cancer Res; 1986 Nov; 46(11):5816-20. PubMed ID: 3530441
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
Svensson HP; Frank IS; Berry KK; Senter PD
J Med Chem; 1998 Apr; 41(9):1507-12. PubMed ID: 9554883
[TBL] [Abstract][Full Text] [Related]
9. Antibody directed targeting of methotrexate-containing small unilamellar vesicles.
Singh M; Faulkner G; Ghose TI; Mezei M
Cancer Immunol Immunother; 1988; 27(1):17-25. PubMed ID: 3293779
[TBL] [Abstract][Full Text] [Related]
10. Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.
Kanellos J; Pietersz GA; McKenzie IF
J Natl Cancer Inst; 1985 Aug; 75(2):319-32. PubMed ID: 2991647
[TBL] [Abstract][Full Text] [Related]
11. Tumor localization and therapeutic potential of an antitumor-anti-CD3 heteroconjugate antibody in human renal cell carcinoma xenograft models.
Zhu Z; Ghose T; Lee SH; Fernandez LA; Kerr LA; Donohue JH; McKean DJ
Cancer Lett; 1994 Oct; 86(1):127-34. PubMed ID: 7954349
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human B-cell chronic lymphocytic leukemia by a monoclonal antibody in xenograft models.
Zhu Z; Ghose T; Hoskin D; Lee CL; Fernandez LA; Rowden G; Lee SH
Int J Cancer; 1994 Feb; 56(3):439-45. PubMed ID: 8314332
[TBL] [Abstract][Full Text] [Related]
13. Tumor localization of monoclonal antibodies against human renal carcinoma in a xenograft model.
Guha AK; Ghose T; Singh M; Aquino J; Blair AH; Luner SJ; Mammen M
Cancer Lett; 1991 Dec; 61(1):35-43. PubMed ID: 1764696
[TBL] [Abstract][Full Text] [Related]
14. Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice.
Marumo K; Oya M; Murai M; Tazaki H
Int J Urol; 1996 Jan; 3(1 Suppl):S24-7. PubMed ID: 24304015
[TBL] [Abstract][Full Text] [Related]
15. Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma.
Kito A; Yoshida J; Kageyama N; Kojima N; Yagi K
J Neurosurg; 1989 Sep; 71(3):382-7. PubMed ID: 2769390
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
[TBL] [Abstract][Full Text] [Related]
17. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
[TBL] [Abstract][Full Text] [Related]
18. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-gamma-dimyristoylphosphatidylethanolamine.
Noé C; Hernandez-Borrell J; Kinsky SC; Matsuura E; Leserman L
Biochim Biophys Acta; 1988 Dec; 946(2):253-60. PubMed ID: 3207742
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of carbohydrate-linked murine monoclonal antibody K20-human serum albumin conjugates.
Kondejewski LH; Kralovec JA; Blair AH; Ghose T
Bioconjug Chem; 1994; 5(6):602-11. PubMed ID: 7873663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
